Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
An update on the management of chronic hepatitis B and C infection
Dost Sarpel
, Danielle Carter
, Isaac Wasserman
, Moriah Oxnard
,
Douglas T. Dieterich
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'An update on the management of chronic hepatitis B and C infection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Patient Demographics
100%
Chronic Hepatitis B Virus Infection
100%
Chronic Hepatitis B Infection
100%
SVR12
100%
Direct-acting Antivirals
100%
Chronic Hepatitis C Infection
100%
Functional Cure
100%
Hepatitis C Virus Therapy
50%
Chronic Kidney Disease
50%
Liver
50%
Hepatitis B Virus
50%
Novel Therapies
50%
Novel Agents
50%
Current Therapies
50%
Decompensated Cirrhosis
50%
Virus Life Cycle
50%
Nucleos(t)ide Analogues
50%
Chronic Hepatitis C Virus Infection
50%
Difficult-to-treat Patients
50%
HIV Co-infection
50%
Medicine and Dentistry
Infection
100%
Chronic Hepatitis B
100%
Chronic Hepatitis C
100%
Patient Population
50%
Antiviral Drug
50%
Virotherapy
25%
Hepatitis C Virus
25%
Human Immunodeficiency Virus
25%
Chronic Kidney Disease
25%
Hepatitis B Virus
25%
Hope
25%
Mixed Infection
25%
Decompensated Liver Cirrhosis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Chronic Hepatitis B
100%
Chronic Hepatitis C
100%
Antiviral Drug
50%
HIV
25%
Chronic Kidney Failure
25%
Hepatitis B Virus
25%
Mixed Infection
25%
Hepatitis C Virus
25%
Decompensated Liver Cirrhosis
25%
Virotherapy
25%